Strategic Growth Expanded service offering with new Epioxa corneal cross-linking therapy for keratoconus signals potential for cross-selling additional ophthalmic procedures and treatment plans to existing patients and referrals.

Clinical Leadership Board-certified physicians with extensive surgical experience and active research presence create opportunities to partner on trials, device testing, and technology partnerships with ophthalmic vendors and startups.

Tech Enablement Adoption of healthcare IT and marketing tech (HIPAA-compliant systems, iCIMS, Webflow, WordPress, Google Workspace) suggests potential for CRM-driven outreach, patient engagement campaigns, and analytics-enabled sales targeting.

Industry Presence Participation in ASCRS and ongoing research activities enhance credibility for speaking engagements and co-marketing with manufacturers, distributors, and education-focused platforms.

Financial Opportunity Revenue in the mid-range tens of millions with a sizeable patient base and expansive surgical volume indicates capacity for bundled service offerings, partnerships, and preferred vendor programs with equipment and implant suppliers.